Treatment of Ear Infection with Infectious Mononucleosis

Diagnosis and Treatment Algorithm

The American Academy of Pediatrics recommends verifying acute otitis media (AOM) by documenting middle ear effusion with bulging tympanic membrane, as tympanic membrane erythema alone can occur with viral pharyngitis in mono 1
The European Society of Clinical Microbiology and Infectious Diseases states that isolated redness of the tympanic membrane without abnormal landmarks is not an indication for antibiotics 2

The American Academy of Pediatrics suggests using cefdinir (14 mg/kg/day in 1-2 doses) as the preferred first-line agent for children with confirmed AOM and concurrent mono, providing excellent coverage against S. pneumoniae, H. influenzae, and M. catarrhalis 3
Alternative cephalosporins, such as cefuroxime (30 mg/kg/day in 2 divided doses) or cefpodoxime (10 mg/kg/day in 2 divided doses), can be used for children with confirmed AOM and concurrent mono 2, 3

Azithromycin is acceptable but has lower efficacy (77-81% clinical success vs. 90-92% for other agents) for adults with confirmed AOM and concurrent mono 4
Respiratory fluoroquinolones (levofloxacin or moxifloxacin) provide 90-92% efficacy for adults with confirmed AOM and concurrent mono if cephalosporins cannot be used 4

The European Society of Clinical Microbiology and Infectious Diseases recommends continuing antibiotics for 8-10 days in children under 2 years, and 5 days in older children and adults with confirmed AOM and concurrent mono 2
Reassess patients at 48-72 hours if symptoms persist or worsen, and consider treatment failure if no improvement occurs 1, 4

Provide adequate analgesia with acetaminophen or ibuprofen, which is critical especially in the first 24 hours for patients with confirmed AOM and concurrent mono 4
Topical analgesic ear drops may reduce pain within 10-30 minutes for patients with confirmed AOM and concurrent mono, though evidence quality is low 5, 4

If no improvement by 48-72 hours, switch to intramuscular ceftriaxone (50 mg/kg/day for 1-3 days) or clindamycin (30-40 mg/kg/day in 3 divided doses) with or without a third-generation cephalosporin for patients with confirmed AOM and concurrent mono 1, 3

Do not use trimethoprim-sulfamethoxazole or erythromycin-sulfisoxazole as second-line agents due to substantial pneumococcal resistance for patients with confirmed AOM and concurrent mono 1
Avoid systemic corticosteroids for routine AOM treatment, even in mono patients, as they provide no significant benefit and may prolong viral shedding 5
Do not prescribe antibiotics for isolated tympanic membrane erythema without middle ear effusion, as this is common in viral pharyngitis associated with mono 2